Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell Carcinoma (LESS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Seoul National University Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT00945984
First received: July 22, 2009
Last updated: July 25, 2009
Last verified: July 2009
  Purpose

Surgical resection is the only potential curative treatment available for renal cell carcinoma. The purpose of this study is to clarify the surgical and oncologic outcomes of laparoendoscopic single-site radical nephrectomy for localized Renal Cell Carcinoma.


Condition Intervention
Localized Renal Cell Carcinoma
Procedure: Radical nephrectomy

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Comparison of Laparoendoscopic Single-site Radical Nephrectomy With Conventional Laparoscopic Radical Nephrectomy for Localized Renal Cell Carcinoma

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • Surgical outcomes such as operative time, estimated blood loss [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Enrollment: 36
Study Start Date: March 2009
Groups/Cohorts Assigned Interventions
LESS
Patients who underwent LESS radical nephrectomy
Procedure: Radical nephrectomy
Surgical options to treat localized renal cell carcinoma
Conventional laparoscopy
Patients who underwent conventional laparoscopic radical nephrectomy
Procedure: Radical nephrectomy
Surgical options to treat localized renal cell carcinoma

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Tertiary care center

Criteria

Inclusion Criteria:

  • Patients with localized renal cell carcinoma

Exclusion Criteria:

  • Patients with lymph node or distant metastasis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00945984

Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Study Chair: Hyeon Hoe Kim, PhD Seoul National University Hospital
  More Information

No publications provided

Responsible Party: Hyeon Hoe Kim, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT00945984     History of Changes
Other Study ID Numbers: LESSRNx
Study First Received: July 22, 2009
Last Updated: July 25, 2009
Health Authority: Korea: Ministry for Health and Welfare

Keywords provided by Seoul National University Hospital:
Localized renal cell carcinoma

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Renal Cell
Adenocarcinoma
Kidney Diseases
Kidney Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms

ClinicalTrials.gov processed this record on November 24, 2014